{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:05:12Z","timestamp":1793261112900,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007075","name":"European Society for Medical Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["annalsofoncology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.annonc.2024.12.005","type":"journal-article","created":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T19:23:48Z","timestamp":1736969028000},"page":"247-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update"],"prefix":"10.1016","volume":"36","author":[{"given":"N.I.","family":"Cherny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Trapani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Galotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Saar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bricalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Roitberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Gyawali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"Latino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.G.E.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annonc.2024.12.005_bib1","author":"Ferlay"},{"issue":"8","key":"10.1016\/j.annonc.2024.12.005_bib4","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/annonc\/mdw213","article-title":"ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe","volume":"27","author":"Cherny","year":"2016","journal-title":"Ann Oncol"},{"issue":"11","key":"10.1016\/j.annonc.2024.12.005_bib5","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/annonc\/mdx521","article-title":"ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.annonc.2024.12.005_bib7","author":"Trapani"},{"key":"10.1016\/j.annonc.2024.12.005_bib8","author":"Cherny"},{"issue":"10","key":"10.1016\/j.annonc.2024.12.005_bib10","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1093\/annonc\/mdx310","article-title":"ESMO-Magnitude of Clinical Benefit Scale version 1.1","volume":"28","author":"Cherny","year":"2017","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.annonc.2024.12.005_bib12","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/annonc\/mdv249","article-title":"A\u00a0standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncol Magnitude of Clinical Benefit Scale (ESMO-MCBS)","volume":"26","author":"Cherny","year":"2015","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.annonc.2024.12.005_bib13","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S1470-2045(21)00463-0","article-title":"Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey","volume":"22","author":"Fundytus","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.annonc.2024.12.005_bib14","article-title":"Cancer medicines: What is essential and affordable in India?","volume":"8","author":"Sengar","year":"2022","journal-title":"JCO Global Oncol"},{"issue":"1","key":"10.1016\/j.annonc.2024.12.005_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2021.100362","article-title":"Prioritising systemic cancer therapies applying ESMO\u2019s tools and other resources to assist in improving cancer care globally: the Kazakh experience","volume":"7","author":"Latino","year":"2022","journal-title":"ESMO Open"},{"issue":"10","key":"10.1016\/j.annonc.2024.12.005_bib16","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jval.2023.05.017","article-title":"Adaptive health technology assessment: a scoping review of methods","volume":"26","author":"Nemzoff","year":"2023","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.annonc.2024.12.005_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/02763869.2019.1693231","article-title":"Global health observatory data repository","volume":"39","author":"Vardell","year":"2020","journal-title":"Med Ref Serv Q"},{"key":"10.1016\/j.annonc.2024.12.005_bib28","first-page":"14","article-title":"Increasing access to cancer care: how can we guide and track actions by pharmaceutical companies?","volume":"18","author":"Boyer","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.annonc.2024.12.005_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2022.102671","article-title":"Global drug diffusion and innovation with the medicines patent pool","volume":"85","author":"Wang","year":"2022","journal-title":"J\u00a0Health Econ"},{"issue":"6","key":"10.1016\/j.annonc.2024.12.005_bib30","doi-asserted-by":"crossref","first-page":"e250","DOI":"10.1016\/S1470-2045(22)00304-7","article-title":"New coalition to increase access to cancer medicines in LMICs","volume":"23","author":"Burki","year":"2022","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.1016\/j.annonc.2024.12.005_bib31","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.annonc.2023.06.011","article-title":"ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe","volume":"34","author":"Bayle","year":"2023","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753424049809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753424049809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T01:39:11Z","timestamp":1772329151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753424049809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0923753424049809"],"URL":"https:\/\/doi.org\/10.1016\/j.annonc.2024.12.005","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESMO Global Consortium Study on the availability, out-of-pocket costs, and accessibility of cancer medicines: 2023 update","name":"articletitle","label":"Article Title"},{"value":"Annals of Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annonc.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Society for Medical Oncology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}